Sort
130,381 grants matching “hiv”
Formulation development and testing of a novel non-hormonal intravaginal ring to prevent pregnancy and sexually transmitted infections
$871,861Bruce F Variano · Population Council · P50 · FY2021 · HD
EBV NUCLEAR PROTEINS IN B CELL GROWTH TRANSFORMATION
$871,854Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2006 · CA
Exploring the role of the Wnt/B-catenin signaling pathway on HIV reservoir
$871,843Maud Mavigner · Emory University · R56 · FY2021 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Service Core
$871,800Peter Skene · Seattle Children'S Hospital · U19 · FY2024 · AI
RESEARCH CORE: NCMHD-C-SALUD
$871,702Robert Michael Malow · Florida International University · P20 · FY2011 · MD
NIDA Clinical Trials Network: Greater New York Node
$871,690John P Rotrosen · New York University School Of Medicine · UG1 · FY2015 · DA
Investigation of management and disease manifestations of viral hepatitis
$871,687Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
HIV Proteomic Center for Host-Viral Response Characterization
$871,487Richard D Smith · Battelle Pacific Northwest Laboratories · P01 · FY2008 · DA
SOUTHERN AFRICA-NEW YORK HIV VACCINE TRIALS UNIT
$871,348Medical Research Council Of South Africa · U01 · FY2004 · AI
Immune selection of HIV-1 reservoir cells in human clinical trials
$871,246Mathias Lichterfeld · Brigham And Women'S Hospital · R01 · FY2025 · AI
TOWARDS A MORE RELEVANT MODEL OF HIV INFECTION
$871,200Julie M Overbaugh · Fred Hutchinson Cancer Research Center · DP1 · FY2016 · DA
Novel Concepts for the Eradication of HIV
$871,184Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2013 · DA
Novel pre-coital, non-hormonal multipurpose prevention technology (MPT)
$871,184Thomas Michael Zydowsky · Population Council · R01 · FY2020 · AI
Multilevel Comprehensive HIV Prevention for South African Adolescent Girls and Young Women
$871,171Natasha Kaella Crooks · University Of Illinois At Chicago · UH3 · FY2022 · HD
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2021 · DA
SERVICE NEEDS IN EARLY PSYCHOSIS AND DRUG USE
$871,144New York State Psychiatric Institute · R01 · FY2001 · DA
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
$871,114Donald L Sodora · Seattle Children'S Hospital · R01 · FY2025 · AI
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$871,042Barton F Haynes · Duke University · U19 · FY2020 · AI
Molecular analysis of the mucosal SIVsmm transmission bottleneck
$870,987George M Shaw · University Of Pennsylvania · P01 · FY2014 · AI
Targeting regulators of cellular gene transcription to impact HIV latency
$870,956Douglas D Richman · Veterans Medical Research Fdn/San Diego · P01 · FY2010 · AI
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
$870,946Michael David Alpert · Emmune, Inc · R44 · FY2021 · AI
Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (HISTO-FACT)
$870,925Nathan Bahr · University Of Minnesota · R01 · FY2025 · AI
BLOCKING INFECTIOUS ENTRY OF STD PATHOGENS
$870,914Johns Hopkins University · P01 · FY2003 · AI
STRUCTURE OF THE HIV INITIATION COMPLEX
$870,882University Of Alabama At Birmingham · P01 · FY2001 · GM